GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MannKind Corp (FRA:NNFN) » Definitions » Shiller PE Ratio

MannKind (FRA:NNFN) Shiller PE Ratio : (As of May. 19, 2024)


View and export this data going back to . Start your Free Trial

What is MannKind Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MannKind Shiller PE Ratio Historical Data

The historical data trend for MannKind's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MannKind Shiller PE Ratio Chart

MannKind Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MannKind Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MannKind's Shiller PE Ratio

For the Biotechnology subindustry, MannKind's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MannKind's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MannKind's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MannKind's Shiller PE Ratio falls into.



MannKind Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

MannKind's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, MannKind's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.037/131.7762*131.7762
=0.037

Current CPI (Mar. 2024) = 131.7762.

MannKind Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.699 100.560 -0.916
201409 -0.349 100.428 -0.458
201412 -0.365 99.070 -0.485
201503 -0.370 99.621 -0.489
201506 -0.312 100.684 -0.408
201509 -0.356 100.392 -0.467
201512 -3.029 99.792 -4.000
201603 -0.260 100.470 -0.341
201606 -0.294 101.688 -0.381
201609 1.167 101.861 1.510
201612 0.531 101.863 0.687
201703 -0.159 102.862 -0.204
201706 -0.312 103.349 -0.398
201709 -0.260 104.136 -0.329
201712 -0.237 104.011 -0.300
201803 -0.203 105.290 -0.254
201806 -0.137 106.317 -0.170
201809 -0.137 106.507 -0.170
201812 -0.035 105.998 -0.044
201903 -0.071 107.251 -0.087
201906 -0.062 108.070 -0.076
201909 -0.045 108.329 -0.055
201912 -0.063 108.420 -0.077
202003 -0.036 108.902 -0.044
202006 -0.044 108.767 -0.053
202009 -0.042 109.815 -0.050
202012 -0.090 109.897 -0.108
202103 -0.042 111.754 -0.050
202106 -0.116 114.631 -0.133
202109 -0.017 115.734 -0.019
202112 -0.097 117.630 -0.109
202203 -0.091 121.301 -0.099
202206 -0.104 125.017 -0.110
202209 -0.061 125.227 -0.064
202212 -0.066 125.222 -0.069
202303 -0.037 127.348 -0.038
202306 -0.018 128.729 -0.018
202309 0.009 129.860 0.009
202312 0.009 129.419 0.009
202403 0.037 131.776 0.037

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MannKind  (FRA:NNFN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


MannKind Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of MannKind's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MannKind (FRA:NNFN) Business Description

Traded in Other Exchanges
Address
1 Casper Street, Danbury, CT, USA, 06810
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

MannKind (FRA:NNFN) Headlines

No Headlines